Aug 8, 2022 · The present study suggested that CDCA2 may be a new marker molecule for PRCC and may serve as a targeted therapeutic molecule for PRCC.
Pan-cancer analysis of CDCA2 and its function in papillary renal cell ...
dl.acm.org › doi › fullHtml
The present study suggested that CDCA2 may be a new marker molecule for PRCC and may serve as a targeted therapeutic molecule for PRCC.
Sep 21, 2023 · CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells. Oncol Lett. 2020;19(3):2466–74. Epub 2020/03 ...
People also ask
What is the prognosis for papillary renal cell carcinoma type 2?
What is Pan cancer mutation analysis?
What is the most important prognostic indicator for renal cell carcinoma?
What is the difference between papillary renal cell carcinoma type 1 and 2?
Besides, A retrospective study consisting of 155 patients revealed that CDCA2 was expressed higher in PDAC tumor tissues and correlated with poorer prognosis ...
Comprehensive molecular analyses and experimental validation of ...
www.cell.com › heliyon › fulltext
Jun 14, 2024 · However, the precise functional roles and mechanisms of CDCAs in kidney renal papillary cell carcinoma (KIRP) remain unclear. In this study, RNA ...
Sep 6, 2024 · The Cell Division Cycle Associated 2 (CDCA2) gene is responsible for encoding a targeting subunit of cell-cycle associated protein.
However, the precise functional roles and mechanisms of CDCAs in kidney renal papillary cell carcinoma (KIRP) remain unclear.
A pan-cancer analysis reveals the diagnostic and prognostic role of ...
pubmed.ncbi.nlm.nih.gov › ...
Sep 21, 2023 · CDCA2 can serve as a novel biomarker for the diagnosis and prognosis in pan-cancer, especially in LGG. For the development of novel targeted ...
[2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma]. · Pan-cancer analysis of CDCA2 and its function in papillary renal ...
Tumors are diagnosed and forecasted with a high degree of accuracy by CDCA2, and the quantity of expression CDCA2 is linked to the prognosis of many cancers.